Core Viewpoint - The company announced that its subsidiary, Bole Brain Machine, has recently launched the "Cyberlink AC5" product, which is expected to impact future company performance [2] Group 1 - The "Cyberlink AC5" has been officially launched [2] - Investors can find more details about the product through Bole Brain Machine's WeChat public account [2]

Core Points - The National Medical Products Administration has approved a new industry standard for medical devices using brain-computer interface (BCI) technology, which will take effect on January 1, 2026, addressing long-standing issues of terminology confusion in the field [1] - A series of supportive policies have been introduced in 2023 to facilitate the application of BCI technology in healthcare, including pricing guidelines for invasive and non-invasive BCI services [2][3] - The market for BCI applications in healthcare is projected to reach $40 billion by 2030, with significant potential in serious medical applications and consumer healthcare [4] Policy Developments - In March 2023, the National Healthcare Security Administration issued guidelines for pricing BCI-related medical services, establishing clear pricing categories for invasive and non-invasive procedures [2] - Zhejiang Province has implemented specific pricing for BCI services, with costs set at 6,580 yuan for invasive implantation, 3,150 yuan for removal, and 960 yuan for non-invasive adaptation [2] - In August 2023, Zhejiang Province announced that non-invasive BCI adaptation fees would be included in basic medical insurance, reducing the out-of-pocket cost for patients to 10% [2] Industry Trends - The clarity in pricing is expected to promote standardized applications of BCI technology in healthcare, reducing competition chaos and attracting more investment [3] - Companies are increasingly investing in the "BCI + healthcare" sector, with notable advancements in practical applications, such as the launch of the first domestic BCI-assisted rehabilitation system for upper limb function [5] - Innovative companies like Zhejiang Qiangnao Technology are emerging as key players in the industry, focusing on non-invasive BCI technologies and developing smart prosthetic products [5] Future Outlook - Experts predict that ongoing research will lead to significant improvements in BCI technology, expanding its applications beyond current disease treatments to a broader range of medical fields [6] - The convergence of favorable policies, standards, capital, and technology is seen as a catalyst for the BCI medical application sector, with early movers likely to gain a competitive edge [6]